3D Systems Management
Management criteria checks 1/4
3D Systems' CEO is Jeff Graves, appointed in May 2020, has a tenure of 4.5 years. total yearly compensation is $6.54M, comprised of 13% salary and 87% bonuses, including company stock and options. directly owns 0.77% of the company’s shares, worth €3.19M. The average tenure of the management team and the board of directors is 1.9 years and 7.4 years respectively.
Key information
Jeff Graves
Chief executive officer
US$6.5m
Total compensation
CEO salary percentage | 13.0% |
CEO tenure | 4.5yrs |
CEO ownership | 0.8% |
Management average tenure | 1.9yrs |
Board average tenure | 7.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$348m |
Mar 31 2024 | n/a | n/a | -US$350m |
Dec 31 2023 | US$7m | US$850k | -US$363m |
Sep 30 2023 | n/a | n/a | -US$96m |
Jun 30 2023 | n/a | n/a | -US$122m |
Mar 31 2023 | n/a | n/a | -US$126m |
Dec 31 2022 | US$6m | US$850k | -US$123m |
Sep 30 2022 | n/a | n/a | -US$104m |
Jun 30 2022 | n/a | n/a | US$227m |
Mar 31 2022 | n/a | n/a | US$250m |
Dec 31 2021 | US$9m | US$837k | US$322m |
Sep 30 2021 | n/a | n/a | US$308m |
Jun 30 2021 | n/a | n/a | -US$57m |
Mar 31 2021 | n/a | n/a | -US$85m |
Dec 31 2020 | US$6m | US$489k | -US$150m |
Compensation vs Market: Jeff's total compensation ($USD6.54M) is above average for companies of similar size in the German market ($USD1.03M).
Compensation vs Earnings: Jeff's compensation has increased whilst the company is unprofitable.
CEO
Jeff Graves (63 yo)
4.5yrs
Tenure
US$6,535,630
Compensation
Dr. Jeffrey Alan Graves, also known as Jeff, is Director of Integra LifeSciences Corporation. He is Independent Director of Integra LifeSciences Holdings Corporation from December 12, 2023. Dr. Graves is P...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4.5yrs | US$6.54m | 0.77% € 3.2m | |
Executive Vice President of Industrial Solutions | 4.3yrs | US$2.31m | 0.27% € 1.1m | |
Executive VP | less than a year | US$845.99k | 0.13% € 548.4k | |
Executive VP | 3.3yrs | US$2.10m | 0.12% € 509.5k | |
Co-Founder | no data | no data | 0.43% € 1.8m | |
Executive Vice President of Engineering & Operations | 1.9yrs | no data | 0.11% € 469.2k | |
Treasurer & VP of Investor Relations | no data | no data | no data | |
Senior VP of General Counsel & Corporate Secretary | less than a year | no data | no data | |
President - Regenerative Medicine | less than a year | no data | 0.096% € 396.4k |
1.9yrs
Average Tenure
60.5yo
Average Age
Experienced Management: SYV's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 4.8yrs | US$6.54m | 0.77% € 3.2m | |
Co-Founder | no data | no data | 0.43% € 1.8m | |
Independent Director | 28.8yrs | US$220.00k | 0.36% € 1.5m | |
Independent Director | 9yrs | US$228.76k | 0.24% € 990.7k | |
Independent Director | 25.1yrs | US$245.00k | 0.18% € 750.2k | |
Independent Chairman of the Board | 7.7yrs | US$400.00k | 0.11% € 473.3k | |
Independent Director | 16.8yrs | US$255.00k | 0.11% € 440.6k | |
Independent Director | 7.4yrs | US$240.00k | 0.11% € 468.9k | |
Chair of Medical Advisory Board | 2.5yrs | no data | no data | |
Independent Director | 5.7yrs | US$240.00k | 0.094% € 389.2k | |
Independent Director | 3.9yrs | US$216.24k | 0.088% € 365.2k | |
Independent Director | 2.9yrs | US$218.11k | 0.075% € 307.9k |
7.4yrs
Average Tenure
70yo
Average Age
Experienced Board: SYV's board of directors are considered experienced (7.4 years average tenure).